Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
Olivia Pagani(Swiss Group For Clinical Cancer Research), Prudence A. Francis(Peter MacCallum Cancer Centre), Barbara Walley, Richard D. Gelber(Harvard University), Gini F. Fleming(University of Chicago Medical Center), Carlo Tondini(Ospedale Papa Giovanni XXIII), Henry Gómez(National Cancer Center), Marco Colleoni(European Institute of Oncology), Alan S. Coates(International Breast Cancer Study Group), Giuseppe Viale(University of Milan), István Láng(National Institute of Oncology), Angelo Di Leo(Hospital of Prato), Graziella Pinotti(Medica (Italy)), Meredith M. Regan(Dana-Farber Cancer Institute), Aron Goldhirsch(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 150
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k